Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (141)
  • Testimony (88)
  • Microgram (49)
  • Speech (21)
  • Announcements (3)
  • In the News (1)
  • DEA Administrator Remarks (27)

Publication Type

  • DEA Administrator (27)

Drug Name

  • Fentanyl (5)
  • Narcóticos (opioides) (4)
  • Drugs of Concern (1)
  • Ketamine (1)
  • Methamphetamine (1)
  • Synthetic Opioids (1)
  • Xylazine (1)
Clear All Results
DOCUMENT

Administrator Anne Milgram Delivers Opening Statement Before the House Committee on Appropriations Commerce, Justice, Science Subcommittee

Mayo 07, 2024
DEA Administrator Remarks
"I want to thank the Subcommittee for inviting me to testify today on National Fentanyl Awareness Day. It is appropriate that on National Fentanyl Awareness Day, that I am given the opportunity to highlight for you the national tragedy that is being caused by fentanyl. According to the CDC, in...
Mayo 07, 2024
DOCUMENT

Statement from DEA Administrator Anne Milgram on the Increase in DEA Fentanyl Seizures Containing Xylazine

Abril 26, 2024
DEA Administrator Remarks
WASHINGTON – DEA first warned the public of a sharp increase in fentanyl seizures containing xylazine in our March 2023 Public Safety Alert . Since that time, xylazine’s growing prevalence in the fentanyl supply continues to make the deadliest drug threat facing this country even deadlier. In 2023, 30% of...
Abril 26, 2024
DOCUMENT

Operation Blues Brothers

Noviembre 22, 2023
DEA Administrator Remarks
U.S. Attorney’s Office, District of Columbia Press Conference - November 20, 2023 Fentanyl is the greatest threat to Americans today. It is devastating families across our country and killing Americans from all walks of life. And it is the leading cause of death for Americans between the ages of 18...
Noviembre 22, 2023
DOCUMENT

Statement by the Administrator on DEA’s Settlement Agreement with Truepill Pharmacy

Noviembre 06, 2023
DEA Administrator Remarks
DEA is steadfastly committed to ensuring that all Americans get access to needed medications, while also ensuring patient safety. Stimulants are important medications for both children and adults. They are also Schedule II controlled substances that can be highly addictive and that require the greatest care in prescribing. When inappropriately...
Noviembre 06, 2023
DOCUMENT

Update on the Prescription Stimulant Shortage

Noviembre 01, 2023
DEA Administrator Remarks
Dear Americans, On August 1, 2023, I wrote to you with FDA Commissioner Robert Califf to address the lack of availability of certain prescription stimulant medications. As we said then, the U.S. Food and Drug Administration (FDA)and the Drug Enforcement Administration (DEA) recognize the important role that prescription stimulants play...
Noviembre 01, 2023
DOCUMENT

Justice Department Announces Eight Indictments Against China Based Chemical Manufacturing Companies and Employees

Octubre 03, 2023
DEA Administrator Remarks
“Fentanyl is the deadliest drug threat our nation has ever faced. These eight cases are the result of DEA’s efforts to attack the fentanyl supply chain where it starts — in China. Chinese chemical companies are fueling the fentanyl crisis in the United States by sending fentanyl precursors, fentanyl analogues...
Octubre 03, 2023
DOCUMENT

Statement of Anne Milgram Administrator at a Hearing Entitled Oversight of the Drug Enforcement Administration

Julio 27, 2023
DEA Administrator Remarks
Chair Biggs, Ranking Member Jackson Lee, and distinguished members of the subcommittee: On behalf of the Department of Justice (Department), and in particular the nearly 10,000 employees working at the Drug Enforcement Administration (DEA), thank you for the opportunity to appear before you today to discuss DEA’s work to save...
Julio 27, 2023
DOCUMENT

DEA Administrator's Remarks on China-Based Chemical Manufacturing Companies and Arrests

Junio 23, 2023
DEA Administrator Remarks
“Today’s announcement is a considerable step forward in our unrelenting fight against fentanyl, targeting the threat where it starts. These companies and individuals are alleged to have knowingly supplied drug traffickers, in the United States and Mexico, with the ingredients and scientific know-how needed to make fentanyl – a drug...
Junio 23, 2023
DOCUMENT

Statement from the DEA Administrator Anne Milgram on COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

Mayo 03, 2023
DEA Administrator Remarks
The Drug Enforcement Administration received a record 38,000 comments on its proposed telemedicine rules. We take those comments seriously and are considering them carefully. We recognize the importance of telemedicine in providing Americans with access to needed medications, and we have decided to extend the current flexibilities while we work...
Mayo 03, 2023
DOCUMENT

DOJ and DEA Announce Charges against Chapitos

Abril 14, 2023
DEA Administrator Remarks
“Today’s indictments send a clear message to the Chapitos, the Sinaloa Cartel, and criminal drug networks around the world that the DEA will stop at nothing to protect the national security of the United States and the safety and health of the American people,” said DEA Administrator Anne Milgram. “The...
Abril 14, 2023
Showing 11 - 20 of 27 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Current page 2
  • Página 3
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster